Prognostic predictors of gastrointestinal stromal tumors: A multi-institutional analysis of 102 patients with definition of a prognostic index

European Journal of Surgical Oncology

Volumn 29, Issue 6, 2003, Pages 548-556

  Kontogianni, Kathrina ^a   Demonakou, M ^b   Kavantzas, N ^a   Lazaris, A Ch ^a   Lariou, K ^c   Vourlakou, C ^c   Davaris, P ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b SISMANOGLIO HOSPITAL   (Greece)

^c EVANGELISMOS HOSPITAL   (Greece)

Author keywords

bcl 2; GISTs; Prognosis; Survival

Indexed keywords

CELL MARKER; CYCLINE; KI 67 ANTIGEN; PROTEIN BAX; PROTEIN BCL 2;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER SURGERY; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; LIFE EXPECTANCY; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; METASTASIS; MICROSCOPY; MITOSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL; TUMOR CELL; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 0041475685     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(03)00073-8     Document Type: Article

References (26)

1. Suster S. Gastrointestinal stromal tumors. Semin Diagn Pathol 1996; 13: 297-313.
2. DeMatteo RP, Lewis JJ, Leung D, Muclan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Am Surg 2000; 231: 51-8.
3. Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stomal tumors: recent advances in understanding of their biology. Hum Pathol 1999; 30: 1213-20.
4. Miettinen M, Lasota J. Gastrointestinal stromal tumors-definition, clinical, histological, immunohistochemical and molecular genetic features and differential diagnosis. Virchows Arch 2001; 438: 1-12.
5. Lewin KJ, Appelman HD. Tumors of the Esophagus and Stomach. Atlas of Tumor Pathology. Washington: Armed Forces Institute of Pathology, 1996.
6. Sircar K, Hewlett BR, Huizinga JD, Chorneyko K, Berezin I, Riddell RH. Interstitial cells as precursors of gastrointestinal stromal tumors. Am J Surg Pathol 1999; 23: 377-89.
7. Amin MB, Ma CK, Linden MD, Kubus JJ, Zarbo RJ. Prognostic value of proliferating cell nuclear antigen index in gastric stomal tumors: correlation with mitotic count and clinical outcome. Am J Clin Pathol 1993; 100: 428-32.
8. Rudolph P, Gloeckner K, Parwaresch R, Harms D, Schmidt D. Immunophenotype, proliferation, DNA ploidy and biological behavior of gastrointestinal stromal tumors: a multivariate clinicopathologic study. Hum Pathol 1998; 29: 791-9.
9. Rubin B, Fletcher J, Fletcher C. Molecular insights into histogenesis and pathogenesis of gastrointestinal stromal tumors. Surg Pathol 2000; 8: 5-10.
10. Rudolph R, Chiaravalli AM, Pauser U et al. Gastrointestinal mesenchymal tumors-immunophenotypic classification and survival analysis. Virchows Arch 2002; 441(3): 238-48.
11. Morey AL, Wanigesekera GD, Hawkins NJ, Ward RL. C-kit mutations in gastrointestinal stromal tumors. Pathology 2002; 34(4): 315-9.
12. Martin SJ. Apoptosis and Cancer. San Diego: Karger Landes Systems, 1997.
13. Yang E, Korsmeyer SJ. Molecular thanatopsis: a discourse on the bcl-2 family and cell death. Blood 1996; 88: 386-401.
14. Suster S, Fisher C, Moran C. Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract. Am J Surg Pathol 1998; 22: 863-72.
15. Rosai J. Ackerman's Surgical Pathology, 6th ed. vol. I. New York: Raven, 1980: 430-2.
16. Rosai J. Ackerman's Surgical Pathology, 8th ed. vol. I. New York: Raven, 1996: 645-7.
17. Cox D. Regression models and life tables. J R Statist Soc 1972; 34: 187-220.
18. Haybittle JL, Blamey RW, Elston CW, A prognostic index in primary breast cancer. Br J Cancer 1982; 45: 361-6.
19. Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stomal tumors. Ann Chir Cynaecol 1998; 87: 278-81.
20. Fraquemont D. Differentiation and risk assessment of gastrointestinal stromal tumors. Am J Clin Pathol 1995; 103: 41-7.
21. Akwari OE, Dozois RP, Weiland LH, Beahrs OH. Leiomyosarcoma of the small and large bowel. Cancer 1987; 42: 1375-84.
22. Öfner D, Riehemann K, Maier H et al. Immunohistochemically detectable bcl-2 expression in colorectal carcinoma correlation with tumor stage and patient survival. Br J Cancer 1995; 72: 981-5.
23. Nakopoulou L, Michalopoulou A, Giannopoulou I et al. Bcl-2 protein expression is associated with a prognostically favorable phenotype in breast cancer irrespective of p53 immunostaining. Histopathology 1999; 34: 310-9.
24. Pezzella F, Turley H, Kuzu I et al. Bcl-2 protein in non-small cell lung carcinoma. N Engl J Med 1993; 329(10): 690-4.
25. Ghosh M, Crocker J, Morris AG. CD40 and bcl-2 expression in squamous cell carcinoma of the lung: correlation with apoptosis, survival, and other clinicopathological factors. J Pathol 1999; 189(3): 363-7.
26. Miettinen M, Sarlomo-Rikala M, Kovatich A. Cell type and tumortype-related patterns of bcl-2 reactivity in mesenchymal cells and soft tissue tumours. Virchows Arch 1998; 433: 255-60.